RANDOMIZED CLINICAL TRIAL FRANCE DMLA2-Reference-Cited by-同舟云学术

RANDOMIZED CLINICAL TRIAL FRANCE DMLA2

Published:2012-04 Issue:4 Volume:32 Page:834-843
ISSN:0275-004X
Container-title:Retina
language:en
Short-container-title:

Author:

Cohen Salomon-Yves,Bourgeois Hubert,Corbe Christian,Chaine Gilles,Espinasse-Berrod Marie-Andrée,Garcia-Sanchez Julian,Gaudric Alain,Hullo Alain,Leys Anita,Soubrane Gisèle,Sahel JoséA

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference34 articles.

1. Age-related macular degeneration.;Bressler;Surv Ophthalmol,1988

2. . Prevalence of age-related macular degeneration in the United States.;Friedman;Arch Ophthalmol,2004

3. . Risk factors for incident age-related macular degeneration: pooled findings from 3 continents.;Tomany;Ophthalmology,2004

4. Age related macular degeneration.;Fine;N Engl J Med,2000

5. The role of oxidative stress in the pathogenesis of age-related macular degeneration.;Beatty;Surv Ophthalmol,2000

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Age-Related Macular Degeneration Therapies;Molecules;2022-08-10

2. Umsetzungshilfe zu methodischen Kriterien des CONSORT-Statements zur transparenten Publikation von RCTs in der Augenheilkunde;Klinische Monatsblätter für Augenheilkunde;2019-06-19

3. Geographic Atrophy;Advances in Ophthalmology and Optometry;2018-08

4. Treatments for dry age-related macular degeneration and Stargardt disease: a systematic review;Health Technology Assessment;2018-05

5. Visual Function Metrics in Early and Intermediate Dry Age-related Macular Degeneration for Use as Clinical Trial Endpoints;American Journal of Ophthalmology;2018-05